# GRK6

## Overview
G protein-coupled receptor kinase 6 (GRK6) is a gene that encodes a serine/threonine kinase involved in the regulation of G protein-coupled receptors (GPCRs) through phosphorylation. The protein product, GRK6, plays a pivotal role in the desensitization of GPCRs, which is essential for modulating signal transduction pathways within cells (Loudon1994Expression). As a member of the kinase family, GRK6 is primarily localized in the cytoplasm and cell membrane, where it influences receptor signaling to ensure proper cellular responses (Loudon1994Expression). The kinase is also implicated in various physiological processes, including hematopoietic stem cell maintenance, apoptotic cell clearance, and immune homeostasis (Le2016GRK6; Nakaya2013GRK6). Dysregulation of GRK6 has been associated with several pathological conditions, particularly autoimmune diseases, highlighting its significance in maintaining cellular and systemic equilibrium (Nakaya2013GRK6).

## Structure
GRK6 is a serine/threonine kinase involved in the phosphorylation of G protein-coupled receptors (GPCRs). The protein consists of 576 amino acids, with a predicted molecular mass of approximately 66 kDa (Loudon1994Expression). GRK6 shares high amino acid homology with other kinases such as GRK5, particularly in the protein kinase catalytic domain, where it exhibits 78.7% to 79.5% identity (Loudon1994Expression).

The C-terminal region of GRK6A, a splice variant of GRK6, contains an amphipathic helix motif and cysteine sites crucial for plasma membrane localization through palmitoylation (Jiang2007Plasma). Palmitoylation, a post-translational modification, enhances the kinase activity of GRK6 by anchoring it to the membrane, which is essential for its function in phosphorylating receptors like the β2-adrenergic receptor (Stoffel1998Palmitoylation). GRK6 undergoes alternative splicing, resulting in variants such as GRK6A, GRK6B, and GRK6C, each differing in their C-terminal regions and palmitoylation sites (Stoffel1998Palmitoylation).

The structure of GRK6 includes a large positively charged surface in the kinase region, as revealed by its crystal structure, although detailed information on its secondary, tertiary, or quaternary structures is not provided in the available context (Jiang2007Plasma).

## Function
GRK6 (G protein-coupled receptor kinase 6) is a kinase involved in the phosphorylation and desensitization of G protein-coupled receptors (GPCRs), which is crucial for regulating signal transduction pathways in cells (Loudon1994Expression). This kinase is primarily active in the cytoplasm and cell membrane, where it modulates receptor signaling to ensure appropriate cellular responses (Loudon1994Expression).

In healthy human cells, GRK6 plays a significant role in maintaining hematopoietic stem cell (HSC) self-renewal and differentiation. It regulates DNA-PKcs phosphorylation, which is essential for DNA repair and acts as a reactive oxygen species (ROS) sensor, helping to protect cells against oxidative stress (Le2016GRK6). GRK6 deficiency leads to increased ROS levels and DNA damage in HSCs, indicating its importance in redox homeostasis and stem cell function (Le2016GRK6).

GRK6 is also involved in the clearance of apoptotic cells, a process vital for tissue homeostasis and preventing autoimmune diseases. It enhances the engulfment of apoptotic cells by activating Rac1, a molecule essential for cytoskeletal rearrangement during cell engulfment (Nakaya2013GRK6). This function is critical for maintaining immune homeostasis and preventing the accumulation of dead cells (Nakaya2013GRK6).

## Clinical Significance
Alterations in the expression or function of the GRK6 gene have been linked to several diseases, particularly autoimmune conditions. GRK6 is crucial for the clearance of apoptotic cells by macrophages. Deficiency in GRK6 leads to impaired apoptotic cell clearance, resulting in the accumulation of cellular debris and the potential triggering of autoimmune responses. This has been associated with the development of autoimmune diseases in mice, resembling human systemic lupus erythematosus (SLE), characterized by increased levels of anti-dsDNA antibodies and IgG deposition in the kidneys (Nakaya2013GRK6).

GRK6 deficiency also affects iron homeostasis, as it impairs the clearance of senescent red blood cells by splenic macrophages, leading to iron accumulation in the spleen (Nakaya2013GRK6). In rheumatoid arthritis, a significant decrease in GRK6 expression in peripheral blood mononuclear cells has been observed, suggesting a role in inflammatory responses (Métayé2005Pathophysiological).

In models of arthritis and colitis, GRK6 deficiency exacerbates disease severity by increasing immune cell infiltration and inflammatory responses, indicating its role in modulating immune cell activity and inflammation (Packiriswamy2015G-protein-coupled). These findings suggest that GRK6 is a critical regulator in immune homeostasis and its dysregulation can contribute to autoimmune and inflammatory diseases.

## Interactions
GRK6 interacts with various proteins, playing a significant role in cellular signaling pathways. It is involved in the NFκB signaling pathway, where it phosphorylates IκBα at Ser32/36, a site also targeted by IKKβ. This phosphorylation is implicated in TNFα-induced inflammation in peritoneal macrophages, suggesting a regulatory mechanism in its interaction with IκBα (Packiriswamy2015G-protein-coupled).

GRK6 also interacts with the Na+/H+ exchanger regulatory factor, phosphorylating it by interacting with its C-terminus and the PDZ domain of the factor. This indicates a specific physical interaction between GRK6 and the regulatory factor (Gurevich2012G).

Palmitoylation of GRK6 enhances its kinase activity by anchoring it to the membrane, which facilitates its interaction with receptor substrates like the β2-adrenergic receptor. This modification allows GRK6 to be more active in phosphorylating both receptor and soluble substrates (Stoffel1998Palmitoylation).

GRK6 is also involved in arrestin recruitment to the β2-adrenergic receptor, highlighting its role in receptor desensitization and signaling (Gurevich2012G). These interactions underscore GRK6's involvement in diverse cellular processes through its interactions with various proteins.


## References


[1. (Gurevich2012G) Eugenia V. Gurevich, John J.G. Tesmer, Arcady Mushegian, and Vsevolod V. Gurevich. G protein-coupled receptor kinases: more than just kinases and not only for gpcrs. Pharmacology &amp; Therapeutics, 133(1):40–69, January 2012. URL: http://dx.doi.org/10.1016/j.pharmthera.2011.08.001, doi:10.1016/j.pharmthera.2011.08.001. This article has 501 citations.](https://doi.org/10.1016/j.pharmthera.2011.08.001)

[2. (Jiang2007Plasma) Xiaoshan Jiang, Jeffrey L. Benovic, and Philip B. Wedegaertner. Plasma membrane and nuclear localization of g protein–coupled receptor kinase 6a. Molecular Biology of the Cell, 18(8):2960–2969, August 2007. URL: http://dx.doi.org/10.1091/mbc.e07-01-0013, doi:10.1091/mbc.e07-01-0013. This article has 44 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e07-01-0013)

[3. (Nakaya2013GRK6) Michio Nakaya, Mitsuru Tajima, Hidetaka Kosako, Takeo Nakaya, Akiko Hashimoto, Kenji Watari, Hiroaki Nishihara, Mina Ohba, Shiori Komiya, Naoki Tani, Motohiro Nishida, Hisaaki Taniguchi, Yoji Sato, Mitsuru Matsumoto, Makoto Tsuda, Masahiko Kuroda, Kazuhide Inoue, and Hitoshi Kurose. Grk6 deficiency in mice causes autoimmune disease due to impaired apoptotic cell clearance. Nature Communications, February 2013. URL: http://dx.doi.org/10.1038/ncomms2540, doi:10.1038/ncomms2540. This article has 48 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms2540)

[4. (Stoffel1998Palmitoylation) Robert H. Stoffel, James Inglese, Alexander D. Macrae, Robert J. Lefkowitz, and Richard T. Premont. Palmitoylation increases the kinase activity of the g protein-coupled receptor kinase, grk6. Biochemistry, 37(46):16053–16059, October 1998. URL: http://dx.doi.org/10.1021/bi981432d, doi:10.1021/bi981432d. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi981432d)

[5. (Métayé2005Pathophysiological) Thierry Métayé, Hélène Gibelin, Rémy Perdrisot, and Jean-Louis Kraimps. Pathophysiological roles of g-protein-coupled receptor kinases. Cellular Signalling, 17(8):917–928, August 2005. URL: http://dx.doi.org/10.1016/j.cellsig.2005.01.002, doi:10.1016/j.cellsig.2005.01.002. This article has 110 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2005.01.002)

[6. (Loudon1994Expression) R.P. Loudon and J.L. Benovic. Expression, purification, and characterization of the g protein-coupled receptor kinase grk6. Journal of Biological Chemistry, 269(36):22691–22697, September 1994. URL: http://dx.doi.org/10.1016/s0021-9258(17)31701-5, doi:10.1016/s0021-9258(17)31701-5. This article has 73 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(17)31701-5)

[7. (Le2016GRK6) Qiumin Le, Wenqing Yao, Yuejun Chen, Biao Yan, Cao Liu, Man Yuan, Yuqing Zhou, and Lan Ma. Grk6 regulates ros response and maintains hematopoietic stem cell self-renewal. Cell Death &amp; Disease, 7(11):e2478–e2478, November 2016. URL: http://dx.doi.org/10.1038/cddis.2016.377, doi:10.1038/cddis.2016.377. This article has 22 citations.](https://doi.org/10.1038/cddis.2016.377)

[8. (Packiriswamy2015G-protein-coupled) N Packiriswamy and N Parameswaran. G-protein-coupled receptor kinases in inflammation and disease. Genes &amp; Immunity, 16(6):367–377, September 2015. URL: http://dx.doi.org/10.1038/gene.2015.26, doi:10.1038/gene.2015.26. This article has 44 citations.](https://doi.org/10.1038/gene.2015.26)